PDE5A and glioblastoma: In our experiments, the PDE5 inhibitor MY-5445 at a concentration of 50 μM had a clear inhibitory effect on the migration of all three glioblastoma lines tested, including T98G cells, which was further potentiated by the co-application of 10 μM PF-02545920.